FDA-Drug2017-03-22Class II
Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30 count HDPE bottles, Rx Only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0093-5721-56
Teva Pharmaceuticals USA
Hazard
Failed Impurities/Degradation Specifications
Sold states
Nationwide
Affected count
7,628 HDPE bottles (228,840 tablets)
Manufactured in
1090 Horsham Rd, N/A, North Wales, PA, United States
Products
Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30 count HDPE bottles, Rx Only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0093-5721-56
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0517-2017Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief